GnRH antagonist (Cetrorelix)

DRUG3 trials

Sponsors

Instituto Valenciano de Infertilidad, IVI VALENCIA, Seoul National University Hospital, El Shatby University Hospital for Obstetrics and Gynecology

Conditions

Controlled Ovarian HyperstimulationEffects of GonadotropinInfertilityOocyte MaturationOvarian Hyperstimulation SyndromePolycystic Ovarian SyndromePolycystic Ovary Syndrome

Phase 3

GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

CompletedNCT01268761

Instituto Valenciano de Infertilidad, IVI VALENCIAEffects of Gonadotropin, Oocyte Maturation, Ovarian Hyperstimulation Syndrome

Start: 2012-04-30End: 2013-07-31Updated: 2013-09-19

GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

CompletedNCT01402336

Seoul National University HospitalInfertility, Polycystic Ovary Syndrome

Start: 2011-06-30End: 2016-12-31Updated: 2017-10-10

Unknown Phase

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

CompletedNCT06812559

El Shatby University Hospital for Obstetrics and GynecologyControlled Ovarian Hyperstimulation, Polycystic Ovarian Syndrome

Start: 2023-12-01End: 2025-02-01Updated: 2025-02-25